MARKERS TO PREDICT AND MONITOR RESPONSE TO AURORA KINASE B INHIBITOR THERAPY
摘要
<p>The present invention relates to identifying the presence or absence of one or more copy number gains in the ABCB1 gene, the ABCB4 gene or combinations thereof, identifying patients eligible to receive Aurora kinase inhibitor therapy, either as monotherapy or as part of combination therapy, and monitoring patients' response to such therapy.</p>
申请公布号
WO2010088470(A1)
申请公布日期
2010.08.05
申请号
WO2010US22518
申请日期
2010.01.29
申请人
ABBOTT LABORATORIES;SEMIZAROV, DIMITRI;SHAH, JAMEEL;GUO, JUN;ANDERSON, MARK
发明人
SEMIZAROV, DIMITRI;SHAH, JAMEEL;GUO, JUN;ANDERSON, MARK